ARCHIVES

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

This article is from The Cancer Letter archive.

Vol. 30 No. 04 | January 23, 2004

Download PDF Visit The Full Archive

Related Articles

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

December 4, 1981

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010

CAP Issues Active Surveillance Guidance For Prostate Cancer

September 5, 2014